To Deliver Regenerative Medical Therapies for Unmet Medical Needs.
We value the autonomy of every person and hold ourselves accountable to the improvement of health for all.
We uphold the highest ethical standards for our research.
We endeavor to bring the latest in technology to bear on human disease with experimental rigor.
We utilize innovative cell-based modalities to address complicated multifactorial diseases.
Click here to replay our KOL event, which was held on August 16, 2023, featuring Sunjay Kaushal, MD, PhD and Ram Kumar Subramanyan, MD, PhD, discussing the potential for Medicinal Signaling Cells (MSCs), such as those making up Longeveron’s Lomecel-B™ injection, to improve the outcome for Hypoplastic Left Heart Syndrome (HLHS) patients.
Click Here to Watch the Replay